Skip to content
Search

Latest Stories

RPS issues guidance on new CD regulations for pandemic supply

The Royal Pharmaceutical Society (RPS) has issued guidance for pharmacists on controlled drugs (CDs) regulations for pandemic supply.

Three changes to the Misuse of Drugs Regulations (MDRs) came into force last week, which provide ministers with emergency powers for the supply of CDs.


The purpose of the changes is to ensure community pharmacies can continue to supply patients with essential medicines at critical times of a pandemic period.

The three changes to the MDRs relating to the supply of CDs during pandemic regulations 2020 include:

  1. Emergency supply of a CD without a prescription

At the request of a patient, medicines may be supplied without a prescription, in accordance with the directions of a pharmacist.

CDs may be supplied without prescription if supply is part of NHS services and the contractor complies with those NHS arrangements and the NHS arrangements are within the scope of the minister’s announcement with regard to the area, particular circumstances such as GP practice closure, and period in question up to three months at a time, which can be amended, withdrawn, or extended.

The supervising pharmacist need to be satisfied that the patient has been receiving the medicine as part of ongoing treatment from a relevant prescriber and the dose is appropriate for the patient to supply the medicines without prescription.

  1. Emergency supply of a CD against a Serious Shortage Protocol (SSP)

This provision is essentially the same as that for supply of a CD without a prescription. It enables medicines to be supplied under SSPs, if there is a serious shortage of the medicine and the requirements for SSP supply are satisfied.

  1. Emergency change to a CD instalment direction with the agreement of the prescriber

This provision allows pharmacists without prescribing rights to change the frequency of instalments on instalment prescriptions for medicines of schedule two and three of the MDRs, without the need for a new prescription from the prescriber.

The changed intervals are treated as the intervals of the prescriber.

More For You

Scottish community pharmacist working in high street pharmacy with supportive environment

The PDA wants investment to reach those who deliver services to patients every day

Pic credit: iStock

Funding boost in Scotland “needs to work for not just pharmacy owners but pharmacists too”, says PDA

An increase in funding for community pharmacies in Scotland needs to lead to a greater focus on supporting pharmacists rather than “simply sustain business models”, according to the Pharmacy Defence Association (PDA).

Earlier this week, Community Pharmacy Scotland (CPS) accepted the Scottish government’s initial financial offer for the 2025/26 fiscal year, securing a guaranteed minimum reimbursement of £120 million for community pharmacies — up from £110 million from 2024/25.

Keep ReadingShow less
Aspire Pharma acquisition boosts access to essential medicines for NHS patients in the UK

The acquisition is expected to further drive the company’s growth.

gettyimages

Aspire acquires UK distribution rights from Tetris

Aspire Pharma Limited, one of the UK’s fastest-growing specialty niche generics companies, has announced the acquisition of UK distribution rights to a number of products from Tetris Pharma, a subsidiary of Arecor Therapeutics.

These include products used in the treatment of bacterial infections—such as injectable and intravenous antibiotics—as well as a medicine indicated for acute myocardial infarction (MI) and deep vein thrombosis (DVT).

Keep ReadingShow less
GP surgery upgrades for annual appointments

The surgeries will have additional space to “see more patients, boost productivity and improve patient care”

Pic credit: iStock

GP surgery upgrades to create 8.3 million more annual appointments

Over 1,000 GP surgeries will have their premises modernised to meet the needs of a further 8.3 million appointments each year, the government has announced.

Backed by a cash injection of over £102 million, the surgeries will have additional space to “see more patients, boost productivity and improve patient care”.

Keep ReadingShow less
Wales boosts funding for pharmacy-led UTI and sore throat test services

The sore throat test (STTT) and treat service will be widely available

Pic credit: istock

Welsh pharmacies receive funding boost for clinical services

Two key clinical services will be available in 99 per cent of community pharmacies across Wales after a boost in funding.

The sore throat test (STTT) and treat service and the urinary tract infection (UTI) service have both benefitted from contractual negotiations between the Welsh Government and Community Pharmacy Wales (CPW).

Keep ReadingShow less
Paul Bennett
Paul Bennett, CEO, Royal Pharmaceutical Society
Paul Bennett, CEO, Royal Pharmaceutical Society

Pharmacists need to take advantage of independent prescribing pathways, says Bennett

Independent prescribing will be a “significant point” in the history of community pharmacy, according to Royal Pharmaceutical Society chief executive Paul Bennett.

Last month, the RPS announced the launch of a comprehensive new prescribing development programme to support pharmacists across all stages of their prescribing careers.

Keep ReadingShow less